Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REGORAFENIB vs REMIMAZOLAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REGORAFENIB vs REMIMAZOLAM: Safety Overview

Metric REGORAFENIB REMIMAZOLAM
Total FAERS Reports 9,441 137
Deaths Reported 1,869 3
Death Rate 19.8% 2.2%
Hospitalizations 3,363 24
Average Patient Age 62.2 yrs 60.4 yrs
% Female Patients 39.9% 41.5%
FDA Approval Date Jan 13, 2025 Oct 6, 2020
Manufacturer Bayer HealthCare Pharmaceuticals Inc. Acacia Pharma, Ltd.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription